Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.

NCT01193335 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

13-valent Pneumococcal Vaccine
Premature Birth
Immunization
Safety

Interventions

BIOLOGICAL: 13-valent pneumococcal conjugate vaccine
BIOLOGICAL: 13-valent pneumococcal conjugate vaccine

Sponsor

Pfizer